logo
logo

Latent Labs raised $50M in a Series A funding round co-led by Radical Ventures and Sofinnova Partners to accelerate progress in programmable biology.

Feb 13, 2025•5 months ago

Amount Raised

$50 Million

Round Type

series a

LondonTherapeuticsArtificial IntelligenceBiotechnology

Investors

Aidan GomezJeff DeanPillar VcKindred Capital8 VcIsomerFlying FishSofinnova PartnersRadical Ventures

Description

Latent Labs has emerged from stealth, announcing a total funding of $50 million to enhance their research in programmable biology. The funding includes a significant $40 million in a Series A round, which will be used to empower researchers to create new therapeutic molecules.

Company Information

Company

Latent Labs

Location

London, England, United Kingdom

About

Latent Labs is an AI foundation model builder focused on programmable biology. Founded by Dr. Simon Kohl, the company aims to empower researchers to computationally create new therapeutic molecules like antibodies and enzymes. Their platform provides tools that expedite drug development timelines and improve the success rates of finding therapeutic molecules. With a team composed of talent from leading tech and biotech firms, Latent Labs is pioneering advancements in generative biology.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People